CryoValve Allograft, heart valve
FDA device recall Z-0673-03 · posted 2003-03-21 · Terminated
Recall details
- Recalling firm
- Cryolife Inc
- Reason for recall
- Microorganisms were detected in distributed donor tissue.
- Action taken
- Medical facilities were contacted by CryoLife Technical Representatives via letter on/about 2/20/2003 to alert the facility of the removal and to determine the disposition of the allografts. Firms were advised, if the tissue has not been implanted, not to implant or distribute the tissue and to place it into quarantine. Consignees were to contact CryoLife''s Regulatory Affairs Department-Field Assurance, and a representative would issue a Return Materials Authorization number and will provide specific instructions for returning the tissue. There is a stamped, self addressed postcard attached to affirm receipt of the notification.
- Root cause
- Other
- Status
- Terminated
- Product code
- MIE
- Quantity affected
- There were six (6) individual heart valve allografts.
- Distribution
- Tissue products were distributed to Medical facilities located in CA, MD, ME and SD. There were no foreign or government accounts.
- Date initiated
- 2003-02-18
- Date posted
- 2003-03-21
- Date terminated
- 2003-07-21
- Location
- Kennesaw, GA
Monitor recalls programmatically
Recalls and clearances share one API, with change alerts when new recalls post.